| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.6 |